Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rachel J. Keogh"'
Autor:
Rachel J. Keogh, MB BCH BAO, Martin P. Barr, PhD, Anna Keogh, MB BCH BAO, David McMahon, MB BCH BAO, Cathal O’Brien, PhD, Stephen P. Finn, MD, Jarushka Naidoo, MBBCH, MHS
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100627- (2024)
Introduction: The identification of genomic “targets” through next-generation sequencing (NGS) of patient’s NSCLC tumors has resulted in a rapid expansion of targeted treatment options for selected patients. This retrospective study aims to ide
Externí odkaz:
https://doaj.org/article/7485f09829ab430c9cdf25af69656df9
Autor:
Rachel J. Keogh, John C. Riches
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7355-7378 (2022)
Breath analysis is a promising non-invasive method for the detection and management of lung cancer. Exhaled breath contains a complex mixture of volatile and non-volatile organic compounds that are produced as end-products of metabolism. Several stud
Externí odkaz:
https://doaj.org/article/2fe2b3efa0f747c3b528d6d026e36e1d
Autor:
Rachel J. Keogh, Razia Aslam, Maeve A. Hennessy, Zac Coyne, Bryan T. Hennessy, Oscar S. Breathnach, Liam Grogan, Patrick G. Morris
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Following optimal local therapy, adjuvant Procarbazine, Lomustine and Vincristine (PCV) improves overall survival (OS) in low-grade glioma (LGG). However, 1 year of PCV is associated with significant toxicities. In the pivotal RTO
Externí odkaz:
https://doaj.org/article/8a8e86d631dc496780b61a82416dbf04
Autor:
Catherine S. Weadick, Rachel J. Keogh, Hailey K. Carroll, Sandra Boldrin, Eibhlin Mulroe, Lucy Murphy, Bryan Sheils, Aisling Barry, Seamus O’Reilly
Publikováno v:
Journal of Cancer Policy. 35:100410
Autor:
Razia Aslam, Z. Coyne, Maeve A. Hennessy, Rachel J. Keogh, Patrick G. Morris, Oscar S. Breathnach, Bryan T. Hennessy, Liam Grogan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background Following optimal local therapy, adjuvant Procarbazine, Lomustine and Vincristine (PCV) improves overall survival (OS) in low-grade glioma (LGG). However, 1 year of PCV is associated with significant toxicities. In the pivotal RTOG 9802 ra